Q3 results: Pfizer, Zydus Lifesciences, Aurobindo Pharma, 181 more on Feb 9

Earnings Reports - A total of 184 firms are scheduled to announce their earnings report for the third quarter (Q3FY26), including notable companies such as Zydus Lifesciences, Aurobindo Pharma, and Pfizer [1] - Other companies expected to declare their Q3 results include Happiest Minds Technologies, Route Mobile, and Kaveri Seed Company [2] State Bank of India (SBI) Performance - SBI reported a net profit of ₹21,028 crore for Q3FY26, marking a 24.5% year-on-year increase, attributed to strong growth in non-interest income and steady net interest income [3][4] - The bank's net interest income grew by 9% annually to ₹45,190 crore, with advances expanding by over 15% year-on-year to ₹46.83 trillion [4] - Non-interest income surged by 66% year-on-year to ₹18,359 crore, primarily driven by higher fee income [4] Net Interest Margin (NIM) - SBI's domestic net interest margin improved by 3 basis points to 3.12% at the end of Q3FY26, compared to 3.09% in the previous quarter and 3.15% in the same period last year [5] - The bank anticipates its NIM to remain above 3% in the future [5] Market Overview - Indian equity benchmark indices, Sensex and Nifty, are expected to open strongly, supported by positive global cues and optimism surrounding the India–US Interim Trade Agreement [6] - Market sentiment improved following a joint statement from India and the US outlining the framework for the Interim Trade Agreement, which is seen as a precursor to a comprehensive Bilateral Trade Agreement [7] - US President Donald Trump lifted a 25% tariff on Indian goods, enhancing market optimism [8] Asian Market Performance - Early indicators suggest a firm start for domestic equities, with GIFT Nifty trading at 25,938.5, up 241 points or 0.94% [9] - Asian markets are also experiencing gains, particularly in Japan, where the Nikkei 225 surged by 4.5% [9]